This data provides evidence for the downregulation of BiP in hepatic tissues exhibiting FH conditions, similar to the depleted BiP expression manifested in the hepatic tissues of NASH patients. Here, HSPA5 is linked to metabolic dysfunction-associated steatohepatitis.